Fierce Biotech August 19, 2022
Andrea Park

EchoNous’ artificial-intelligence-powered system already majorly cuts down on the amount of specialized equipment traditionally required to perform heart, lung and abdominal ultrasounds. It swaps the usual bulky, cart-based machines for a simple hand-held device and connected tablet.

A new partnership with Samsung aims to simplify the EchoNous system’s profile even further—and send its costs down in the process.

Through the partnership, which the duo announced Thursday, healthcare providers will be able to use the Kosmos hand-held ultrasound system with Samsung’s Galaxy Tab Active Pro tablets, rather than being confined to EchoNous’ own Kosmos Bridge display.

Like Kosmos’ offering, the Galaxy Tab Active devices are designed for intensive workplace use. They feature a long-lasting battery and resistance not...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Digital Health, mHealth, Partnerships, Technology, Trends
The Future of AI in Hospice Care
AI Curation In Tomorrow’s World Will Be Different
Medeloop Raises $15.5M for AI-Driven Medical Research Platform
NVentures Invests in Genesis Therapeutics’ AI Platform for Drug Development
How Do You Construct a Safe, Effective Algorithm?

Share This Article